ilShinbiobase 2026 Q1 Sales and Operating Profit Up, Dividend Planned
-
2026 Q1 sales KRW 2,518M (+33.5% YoY), operating profit KRW 454M, net profit KRW 975M, EPS KRW 23.
-
Debt ratio 11.22%, very low financial stability.
-
Order backlog KRW 12,722M (32 units).
-
2025 annual dividend of KRW 416.8M (approx. KRW 10 per share) planned.
-
Allowance for trade receivables KRW 609M (22.6% of receivables) a burden.
-
Treasury shares 2,539,382 (5.74%) held but no additional cancellation plan.
KOSDAQ Filing Information
-
Filing: Quarterly Report (2026.03)
-
Company: ilShinbiobase (068330)
-
Submission: ilShinbiobase Co., Ltd.
-
Receipt: 05-14-2026